Oxytetracycline-nystatin in the prevention of candidal vaginitis.
D000328:Adult; D002175:Candida / Q000302:isolation & purification; D002181:Candidiasis, Vulvovaginal / Q000209:etiology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000009:adverse effects; D005243:Feces / Q000382:microbiology; D005260:Female; D006801:Humans; D009761:Nystatin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010118:Oxytetracycline / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013223:Statistics as Topic; D014621:Vagina / Q000382:microbiology
D003276:Contraceptives, Oral; D009761:Nystatin; D010118:Oxytetracycline